BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2

Melissa Cline(University of California, Santa Cruz), Rachel G. Liao(Broad Institute), Michael T. Parsons(QIMR Berghofer Medical Research Institute), Benedict Paten(University of California, Santa Cruz), Faisal Alquaddoomi(University of California, Los Angeles), Antonis C. Antoniou(University of Cambridge), Samantha Baxter(University of California, Santa Cruz), Larry Brody(National Human Genome Research Institute), Robert Cook‐Deegan(Institute for the Future), Amy Coffin(University of California, Santa Cruz), Fergus J. Couch(Mayo Clinic in Florida), Brian Craft(University of California, Santa Cruz), Robert Currie(University of California, Santa Cruz), Chloe C. Dlott(University of California, Santa Cruz), Lena Dolman(Ontario Genomics), Johan T. den Dunnen(Leiden University Medical Center), Stephanie O. M. Dyke(McGill University), Susan M. Domchek(University of Pennsylvania), Douglas F. Easton(University of Cambridge), Zachary Fischmann(University of California, Santa Cruz), William D. Foulkes(McGill University), Judy E. Garber(Harvard University), David E. Goldgar(University of Utah), Mary J. Goldman(University of California, Santa Cruz), Peter Goodhand(Ontario Genomics), Steven M. Harrison(Harvard University), David Haussler(University of California, Santa Cruz), Kazuto Kato(The University of Osaka), Bartha Maria Knoppers(McGill Genome Centre), Charles Markello(University of California, Santa Cruz), Robert L. Nussbaum(Invitae (United States)), Kenneth Offit(Memorial Sloan Kettering Cancer Center), Sharon E. Plon(Baylor College of Medicine), Jem Rashbass(Public Health England), Heidi L. Rehm(Brigham and Women's Hospital), Mark E. Robson(Memorial Sloan Kettering Cancer Center), Wendy S. Rubinstein(American Society of Clinical Oncology), Dominique Stoppa‐Lyonnet(Institut Curie), Sean V. Tavtigian(Harvard University), Adrian Thorogood(Ontario Genomics), Can Zhang(University of California, Santa Cruz), Marc Zimmermann(University of Zurich), BRCA Challenge Authors(Centre for Life), John Burn(Centre for Life), Stephen J. Chanock(SIB Swiss Institute of Bioinformatics), Gunnar Rätsch(SIB Swiss Institute of Bioinformatics), Amanda B. Spurdle(QIMR Berghofer Medical Research Institute)
PLoS Genetics
December 26, 2018
Cited by 207Open Access
Full Text

Abstract

The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Genomics and Health (GA4GH) to aggregate BRCA1 and BRCA2 data to support highly collaborative research activities. Its goal is to generate an informed and current understanding of the impact of genetic variation on cancer risk across the iconic cancer predisposition genes, BRCA1 and BRCA2. Initially, reported variants in BRCA1 and BRCA2 available from public databases were integrated into a single, newly created site, www.brcaexchange.org. The purpose of the BRCA Exchange is to provide the community with a reliable and easily accessible record of variants interpreted for a high-penetrance phenotype. More than 20,000 variants have been aggregated, three times the number found in the next-largest public database at the project's outset, of which approximately 7,250 have expert classifications. The data set is based on shared information from existing clinical databases-Breast Cancer Information Core (BIC), ClinVar, and the Leiden Open Variation Database (LOVD)-as well as population databases, all linked to a single point of access. The BRCA Challenge has brought together the existing international Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) consortium expert panel, along with expert clinicians, diagnosticians, researchers, and database providers, all with a common goal of advancing our understanding of BRCA1 and BRCA2 variation. Ongoing work includes direct contact with national centers with access to BRCA1 and BRCA2 diagnostic data to encourage data sharing, development of methods suitable for extraction of genetic variation at the level of individual laboratory reports, and engagement with participant communities to enable a more comprehensive understanding of the clinical significance of genetic variation in BRCA1 and BRCA2.


Related Papers

No related papers found

Powered by citation graph analysis